Literature DB >> 10664727

Evaluation of cochlear implantation in post-meningitic adults.

J Thomas1, I M Cheshire.   

Abstract

Meningitis is an important cause of deafness and in some studies has been associated with poorer outcomes in adult patients following cochlear implantation. Of the first 100 adults implanted under the Midland Cochlear Implant Programme, 28 were deafened as a result of meningitis. We compare our experience with these patients with patients with a non-meningitic aetiology. A degree of cochlear ossification was a more common finding in the meningitic group. In six cases (four meningitis, two non-meningitis) ossification was encountered only during surgery, not being apparent on pre-operative radiology. The average scores achieved on auditory tests by the meningitic group were similar to those achieved by non-meningitic patients. At nine months, using only the implant, users were able to identify 54 per cent of common environmental sounds, achieved an average score of 30 words per minute on connected discourse tracking and identified an average of 42 per cent of words correctly in BKB sentences. Poorer outcomes were more commonly associated with cochlear ossification. In patients with cognitive and neurological sequelae, benefits with the implant were not always apparent in the early months, however, with intensive therapy these patients can obtain measurable sustained benefit from their implant.

Entities:  

Mesh:

Year:  1999        PMID: 10664727

Source DB:  PubMed          Journal:  J Laryngol Otol Suppl        ISSN: 0144-2945


  2 in total

1.  Outcomes of Cochlear Implantation in Patients with Post-Meningitis Deafness: A Systematic Review and Narrative Synthesis.

Authors:  Kaajal Singhal; Juhi Singhal; Jameel Muzaffar; Peter Monksfield; Manohar Bance
Journal:  J Int Adv Otol       Date:  2020-12       Impact factor: 1.017

2.  New cochlear implant technologies improve performance in post-meningitic deaf patients.

Authors:  Isabelle Mosnier; Andrea Felice; Gonzalo Esquia; Stéphanie Borel; Didier Bouccara; Emmanuèle Ambert-Dahan; Martine Smadja; Evelyne Ferrary; Olivier Sterkers
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-01-12       Impact factor: 2.503

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.